InsiderClue
Insiders · Profile

Coughlin Timothy

Director at Travere Therapeutics · Director at aTYR PHARMA · Director at FATE THERAPEUTICS · and 1 more. Filing since 12 Feb 2008. CIK 0001376043

TVTX Travere Therapeutics, Inc. Director · 3 trades ATYR aTYR PHARMA INC Director · 1 trade FATE FATE THERAPEUTICS INC Director · 2 trades NBIX NEUROCRINE BIOSCIENCES INC Chief Financial Officer · 32 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX Travere Therapeutics, Inc.
12 Jun 2026
Director
Sold on a plan
10,000
$500.75K
15.1%
TVTX Travere Therapeutics, Inc.
15 May 2026
Director
Sold on a plan
3,250
$141.34K
5.9%
TVTX Travere Therapeutics, Inc.
31 Oct 2025
Director
Sold on a plan
18,000
$630.60K
24.5%
ATYR aTYR PHARMA INC
30 May 2024
Director
Bought
50,000
$87.50K
833%
FATE FATE THERAPEUTICS INC
3 Jun 2022
Director
Sold, plan not stated
1,439
$32.82K
2.4%
NBIX NEUROCRINE BIOSCIENCES INC
6 Feb 2017
Chief Financial Officer
Sold, plan not stated
963
$41.54K
0.7%
NBIX NEUROCRINE BIOSCIENCES INC
3 Feb 2017
Chief Financial Officer
Sold, plan not stated
1,500
$63.83K
1.1%
NBIX NEUROCRINE BIOSCIENCES INC
17 Jan 2017
Chief Financial Officer
Sold, plan not stated
1,750
$71.14K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
10 Jan 2017
Chief Financial Officer
Sold, plan not stated
1,750
$75.90K
1.3%
FATE FATE THERAPEUTICS INC
23 Nov 2016
Director
Bought
56,390
$150.00K
opened
NBIX NEUROCRINE BIOSCIENCES INC
3 Feb 2016
Chief Financial Officer
Sold, plan not stated
1,500
$57.09K
1.1%
NBIX NEUROCRINE BIOSCIENCES INC
19 Jan 2016
Chief Financial Officer
Sold, plan not stated
1,750
$81.71K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
11 Jan 2016
Chief Financial Officer
Sold, plan not stated
1,750
$77.44K
1.3%
NBIX NEUROCRINE BIOSCIENCES INC
16 Oct 2015
Chief Financial Officer
Sold, plan not stated
25,000
$1.19M
16.5%
NBIX NEUROCRINE BIOSCIENCES INC
20 Jul 2015
Chief Financial Officer
Sold, plan not stated
20,000
$1.10M
16.5%
NBIX NEUROCRINE BIOSCIENCES INC
13 Jul 2015
Chief Financial Officer
Sold, plan not stated
20,000
$1.00M
16.5%
NBIX NEUROCRINE BIOSCIENCES INC
8 Jun 2015
Chief Financial Officer
Sold, plan not stated
60,000
$2.70M
37.2%
NBIX NEUROCRINE BIOSCIENCES INC
20 Mar 2015
Chief Financial Officer
Sold, plan not stated
40,000
$1.78M
28.3%
NBIX NEUROCRINE BIOSCIENCES INC
16 Jan 2015
Chief Financial Officer
Sold, plan not stated
1,750
$53.92K
1.7%
NBIX NEUROCRINE BIOSCIENCES INC
12 Jan 2015
Chief Financial Officer
Sold, plan not stated
1,750
$49.65K
1.7%
NBIX NEUROCRINE BIOSCIENCES INC
8 Jan 2015
Chief Financial Officer
Sold, plan not stated
10,000
$272.50K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
19 Dec 2014
Chief Financial Officer
Sold, plan not stated
10,000
$240.20K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
18 Dec 2014
Chief Financial Officer
Sold, plan not stated
20,000
$463.60K
17.0%
NBIX NEUROCRINE BIOSCIENCES INC
10 Dec 2014
Chief Financial Officer
Sold, plan not stated
20,000
$429.50K
17.0%
NBIX NEUROCRINE BIOSCIENCES INC
28 Nov 2014
Chief Financial Officer
Sold, plan not stated
10,000
$201.40K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
31 Oct 2014
Chief Financial Officer
Sold, plan not stated
10,000
$190.00K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
30 Oct 2014
Chief Financial Officer
Sold, plan not stated
10,000
$186.20K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
28 Oct 2014
Chief Financial Officer
Sold, plan not stated
10,000
$180.00K
9.3%
NBIX NEUROCRINE BIOSCIENCES INC
10 Jan 2014
Chief Financial Officer
Sold, plan not stated
1,750
$32.48K
1.8%
NBIX NEUROCRINE BIOSCIENCES INC
7 Jan 2014
Chief Financial Officer
Sold, plan not stated
70,000
$1.17M
42.1%
NBIX NEUROCRINE BIOSCIENCES INC
21 Aug 2013
Chief Financial Officer
Sold, plan not stated
19,035
$286.48K
16.5%
NBIX NEUROCRINE BIOSCIENCES INC
5 Aug 2013
Chief Financial Officer
Sold, plan not stated
10,965
$164.37K
10.2%
NBIX NEUROCRINE BIOSCIENCES INC
28 Feb 2011
VP and Chief Financial Officer
Sold, plan not stated
12,320
$84.10K
11.4%
NBIX NEUROCRINE BIOSCIENCES INC
1 Mar 2010
VP and Chief Financial Officer
Sold, plan not stated
12,650
$31.97K
14.4%
NBIX NEUROCRINE BIOSCIENCES INC
12 Jan 2010
VP and Chief Financial Officer
Sold, plan not stated
8,697
$21.95K
13.8%
NBIX NEUROCRINE BIOSCIENCES INC
30 Mar 2009
VP and Chief Financial Officer
Sold, plan not stated
12,117
$41.54K
21.7%
NBIX NEUROCRINE BIOSCIENCES INC
13 Jan 2009
VP and Chief Financial Officer
Sold, plan not stated
8,463
$28.65K
27.3%
NBIX NEUROCRINE BIOSCIENCES INC
12 Feb 2008
VP and Chief Financial Officer
Sold, plan not stated
7,857
$39.45K
40.2%
38 decisions on file.